phone icon (917) 310-3371 Explore Opioid Addiction Treatment Menu
close menu
Nao Medical Logo

Opioid addiction treatment in NYC and Long Island

Find medication for addiction treatment across the Nao Medical network, including Suboxone-based care, bridge review, fentanyl dependence planning, and repeat local follow-up.

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters.

For patients using a self-pay path for Suboxone-based care, current self-pay pricing is $350 for the initial visit including UDS, $200 for follow-up visits including UDS, and $100 for a short bridge visit when clinically appropriate.

Medication for addiction treatment works best when follow-up, behavioral-health support, and realistic clinic access are all handled as part of the same care plan.

Nao Medical clinic visit
Nao Medical clinic interior
Nao Medical patient care
Fast access still needs a real plan A strong opioid-treatment page should make the care path obvious: same-day review when possible, safe timing, insurance or self-pay clarity, and follow-up that actually fits the patient’s life.

What the MAT program actually covers

Nao Medical offers opioid addiction treatment and medication for addiction treatment across NYC and Long Island, including Suboxone-based care, monthly Sublocade or VIVITROL review, bridge-visit support, fentanyl dependence planning, and coordination with therapy or psychiatry when needed. Fentanyl dependence can make withdrawal timing and medication starts more nuanced. The first visit should focus on recent opioid use, current symptoms, prior buprenorphine experience, and a safer start plan rather than rushed promises.

Who these visits are built for

The program is designed for opioid use disorder, including fentanyl dependence, prescription opioid dependence, relapse recovery, and longer-term medication-assisted treatment follow-up.

What the first visit can cover

The first visit can review opioid use history, recent fentanyl or prescription-opioid exposure, withdrawal timing, medication safety, urine drug screening, and whether Suboxone, Sublocade, or VIVITROL makes sense that day.

What same-day access really means

Same-day access can mean same-day evaluation, same-day treatment planning, or same-day medication start when it is clinically appropriate and scheduling allows. It does not mean every patient should be started on medication without a timing and safety review.

Coverage and self-pay

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters. For patients using a self-pay path for Suboxone-based care, current self-pay pricing is $350 for the initial visit including UDS, $200 for follow-up visits including UDS, and $100 for a short bridge visit when clinically appropriate.

MAT locations across New York

Open the local page that fits the day best for directions, scheduling, bridge-review context, and neighborhood-specific details.

Astoria opioid addiction treatment clinic

Queens

Astoria

37-15 23rd Ave, Astoria, NY 11105

A western Queens location for opioid addiction treatment, buprenorphine follow-up, and realistic neighborhood access.

View local MAT page Get directions
Crown Heights opioid addiction treatment clinic

Brooklyn

Crown Heights

341 Eastern Pkwy, Brooklyn, NY 11216

A central Brooklyn location for medication for addiction treatment, follow-up planning, and local access that is easier to keep using.

View local MAT page Get directions
Hicksville opioid addiction treatment clinic

Long Island

Hicksville

232 W Old Country Rd, Hicksville, NY 11801

A Long Island location for opioid addiction treatment, medication follow-up, and insurance-supported recovery care.

View local MAT page Get directions
Mineola opioid addiction treatment clinic

Long Island

Mineola

135 Mineola Blvd, Mineola, NY 11501

A core Long Island location for opioid addiction treatment, insurance review, and reliable ongoing follow-up.

View local MAT page Get directions

Same-day access, bridge visits, and fentanyl planning

Same-day access can mean same-day evaluation, same-day treatment planning, or same-day medication start when it is clinically appropriate and scheduling allows. It does not mean every patient should be started on medication without a timing and safety review.

Bridge prescriptions or bridge visits may be available when clinically appropriate, but they depend on assessment, medication history, safety review, and a concrete next-step plan rather than an automatic refill request.

Fentanyl dependence can make withdrawal timing and medication starts more nuanced. The first visit should focus on recent opioid use, current symptoms, prior buprenorphine experience, and a safer start plan rather than rushed promises.

How treatment moves forward

Assessment and timing review

The first step is understanding what opioids were used, when they were last used, and whether it is clinically safe to start or restart buprenorphine-based treatment.

Suboxone as the main backbone

The Suboxone family is the main child program in this cluster for patients who need repeat follow-up, stabilization, and practical local access.

Bridge review when needed

Some patients need a short-gap plan to keep treatment moving. That still requires assessment, medication history review, and a defined next visit.

Fentanyl-specific planning

Patients dealing with fentanyl dependence often need clearer timing review and closer follow-up before medication starts or restarts.

Related program pages

Suboxone treatment program

The Suboxone hub is the main child program in this cluster for patients who need buprenorphine-based medication treatment and repeat follow-up.

Monthly Sublocade option

The Sublocade family is useful for patients reviewing a longer-acting injectable option after buprenorphine-based treatment is already part of the plan.

Monthly VIVITROL option

The VIVITROL family is useful when the question is about monthly injectable naltrexone for alcohol dependence or relapse prevention after opioid detoxification.

Same-day access

Use the same-day page for urgent access questions, timing review, and what a fast intake can realistically accomplish.

Insurance coverage

Use the insurance page for Medicaid, Medicare, commercial-plan, and self-pay questions before booking.

Bridge prescriptions

Use the bridge page when the urgent question is about a short-gap refill or whether a bridge visit is appropriate.

Fentanyl dependence treatment

Use the fentanyl page when the main concern is withdrawal timing, fentanyl exposure, or safer buprenorphine start planning.

Questions about opioid addiction treatment

The program is designed around opioid use disorder, including fentanyl dependence, prescription opioid dependence, relapse recovery, bridge-visit needs, and longer-term medication-assisted treatment follow-up.
Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters.
Same-day access can mean same-day evaluation, same-day treatment planning, or same-day medication start when it is clinically appropriate and scheduling allows. It does not mean every patient should be started on medication without a timing and safety review.
Bridge prescriptions or bridge visits may be available when clinically appropriate, but they depend on assessment, medication history, safety review, and a concrete next-step plan rather than an automatic refill request.
Fentanyl dependence can make withdrawal timing and medication starts more nuanced. The first visit should focus on recent opioid use, current symptoms, prior buprenorphine experience, and a safer start plan rather than rushed promises.
Yes. Co-occurring mental-health support can be coordinated with therapy, psychiatry, or primary care when that is part of the right plan.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

This made the treatment options much clearer than the average MAT page.

Verified Patient
(4.9)

Helpful that same-day access, insurance, bridge visits, and fentanyl issues were all explained in one place.

Verified Patient
(4.9)

The Suboxone links made it easy to understand the main treatment path without losing the broader context.

Verified Patient
(4.9)

Much better than landing on a generic addiction page with no local details.

Verified Patient
(4.9)

The page felt practical instead of overpromising.

Verified Patient
(4.9)

Clear next steps and clear location options.

Nao medical

Choose a local MAT page next

Use the location pages for directions, scheduling, local details, and the next-step links into Suboxone, Sublocade, or VIVITROL when one of those paths fits better.

See MAT locations